Conduit Pharmaceuticals Inc. 2024 Stock & Warrant Report: Key Insights

$CDT
8-K
Filed on: 2024-12-20
View Source
Conduit Pharmaceuticals Inc. 2024 Stock & Warrant Report: Key Insights

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Company Information:
  • Name: Conduit Pharmaceuticals Inc.
  • Location: 4851 Tamiami Trail North, Suite 200, Naples, FL 34103.
  • Phone Number: (646) 491-9132.
  • SEC CIK Number: 0001896212.
  • SEC File Number: 001-41245.
  • Tax ID: 87-3272543.
  1. Filing Date:
  • The report is dated December 17, 2024.
  1. Stock Information:
  • Common Stock:
    • Par Value: $0.0001 per share.
    • Ticker Symbol: CDT (traded on NASDAQ).
  • Redeemable Warrants:
    • Each warrant is exercisable for one share of common stock at an exercise price of $11.50.
    • Ticker Symbol: CDTTW (traded on NASDAQ).
  1. Contextual Information:
  • The reporting context indicates that this information pertains to the status as of December 17, 2024.
  1. Units of Measure:
  • The financial figures are presented in USD (U.S. Dollars) and shares as the units of measure.

Summary:

Conduit Pharmaceuticals Inc. has reported on its common stock and redeemable warrants as of December 17, 2024. The common stock has a par value of $0.0001 and is listed under the ticker CDT. The redeemable warrants can be exercised at an $11.50 price per share, with the ticker CDTTW. The filing provides essential information for investors and analysts regarding the company's equity structure and potential future equity dilution through the warrants.

You May Also Like